# Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Cancer Treated with Chemotherapy

> **NCT01901094** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 2012 (actual)

## Conditions studied

- Stage II Breast Cancer
- Stage IIIA Breast Cancer

## Interventions

- **PROCEDURE:** Axillary Lymph Node Dissection (ALND)
- **RADIATION:** Nodal Radiation Therapy
- **RADIATION:** Axillary Radiation Therapy

## Key facts

- **NCT ID:** NCT01901094
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-02-24
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 2012 (ACTUAL)
- **Last updated:** 2025-01-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01901094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01901094, "Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Cancer Treated with Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01901094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*